Efficacy News and Research

RSS

Study findings hold promise for children with DMD

Prednisone, the current standard of care used to treat kids with Duchenne muscular dystrophy (DMD), reduces chronic inflammation but has harsh side effects.

11 Feb 2019

Using Therapy Dogs to Reduce Stress and Improve Emotional Well-Being in Vulnerable Individuals

There is much research that shows that therapy dogs can help reduce stress and improve emotional well-being in vulnerable individuals. Rachel McPherson talks about this research that the work done by The Good Dog Foundation.

11 Feb 2019

NIH "Inclusion Across the Lifespan" policy supports research involving underrepresented age groups

The pipeline of research supporting care as we age is about to look a bit more like the country it serves--and for good reason. Beginning this year, the National Institutes of Health (NIH), America's premier institution for medical research, will for the first time in its history require NIH-funded scholars to eliminate arbitrary age limits in their work, age limits that previously allowed for excluding groups like older people without just cause.

11 Feb 2019

Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer

A new UCLA-led study shows that men with low- or intermediate-risk prostate cancer can safely undergo higher doses of radiation over a significantly shorter period of time and still have the same, successful outcomes as from a much longer course of treatment.

11 Feb 2019

Removing 70% or more of the brain hemorrhage could produce better outcomes, study finds

In the first study to identify specific surgical goals for the treatment of an intracerebral hemorrhage--the deadliest and most disabling type of stroke--a team of neurosurgeons found that at least 70 percent of the hemorrhage has to be removed for patients to make a meaningful recovery.

8 Feb 2019

IDT supports innovative synthetic biology start-ups with grant program

Integrated DNA Technologies’ Synthetic Biology Start-up Grant Program has once again benefited innovative start-ups in their missions to impact sustainable manufacturing, human health, and/or humanitarian causes.

From Integrated DNA Technologies 8 Feb 2019

New project aims to develop entomological indicators to assess malaria control tools

The project is led by Professors Ranson and McCall at LSTM, in collaboration with Imperial College, and national medical research institutes in Burkina Faso and Tanzania.

7 Feb 2019

Intense glucose therapy via IV insulin did not improve stroke outcomes, study finds

Intravenous insulin did not improve stroke outcomes compared to standard blood sugar control using insulin shots - answering a worldwide debate about the best way to control glucose in stroke patients.

7 Feb 2019

Researchers show efficacy of new therapy for amyotrophic lateral sclerosis in mice

A team from Université Laval and the CERVO Brain Research Centre has demonstrated the efficacy in mice of a new therapy that addresses the main manifestation of amyotrophic lateral sclerosis.

7 Feb 2019

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

A new treatment for Chlamydia via Canadian researchers

A new way to prevent and treat one of the commonest sexually transmitted infections (STIs) has been developed by the researchers at the University of Manitoba and the University of Waterloo. This new method is more of a gene therapy than antibiotic therapy against the infection.

6 Feb 2019

New breakthrough study can impact drug development and personalized medicine

A breakthrough for brain tumor drug development and personalized medicine published today in Nature Scientific Reports.

6 Feb 2019

Study shows no difference between relief offered by topical pain creams and placebos

In an effort to reduce chronic pain, many people look for hope by paying $20 to thousands of dollars for a tube of prescription topical pain cream or gel.

6 Feb 2019

Compounded pain relief creams not effective finds study

A new study has shown that pain relief creams are no better than dummy or placebo creams when it comes to relieving pain.

6 Feb 2019

Research using fission yeast reveals anticancer mechanism

Much like shoelaces or dangly necklaces, DNA strands can tangle up in unruly knots. Specialized enzymes keep DNA organized when cells divide, so the cells split smoothly and don't get stuck. But in tumor cells, this failsafe allows cancer to spread.

5 Feb 2019

Are Electronic Cigarettes Facilitating Illicit Drug Use?

In this interview, Dr. Michelle Peace provides an introduction to her research into the use of e-cigarettes for the inhalation of illicit drugs.

From Pittcon 5 Feb 2019

Self-care techniques should be first line of treatment for patients with facial pain, suggests study

While oral appliances such as splints and bite guards are the most common treatment for facial pain from temporomandibular disorders, patients rate them as less helpful than self-care treatments, such as jaw exercises or warm compresses, finds a new study by researchers at NYU College of Dentistry.

5 Feb 2019

Study: Promising new treatment for children with ADHD shows improvement in efficacy

A new study in children aged 6 to 12 years of dasotraline, a promising new treatment for attention deficit hyperactivity disorder, showed significant improvement in efficacy in the treatment of ADHD compared to placebo beginning at week 1 and continuing throughout the study.

4 Feb 2019

Researchers unravel path of metallodrug in a breast cancer cell

Some types of cancer cannot be treated with classical chemotherapy. Scientists from Inserm, CNRS, Sorbonne University, PSL university, University Grenoble Alpes and ESRF, the European Synchrotron, are working on a metallorganic molecule as an antitumor drug.

4 Feb 2019

Amprologix wins £1.2 million contract to tackle antimicrobial-resistant MRSA

Amprologix Limited, a University of Plymouth spinout company, has won a £1.2 million contract from the Department for Health and Social Care to accelerate development and scale up its lead antibiotic candidate to tackle antimicrobial resistant MRSA and related superbugs.

4 Feb 2019

Efficacy News and Research

Study findings hold promise for children with DMD

Using Therapy Dogs to Reduce Stress and Improve Emotional Well-Being in Vulnerable Individuals

NIH "Inclusion Across the Lifespan" policy supports research involving underrepresented age groups

Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer

Removing 70% or more of the brain hemorrhage could produce better outcomes, study finds

IDT supports innovative synthetic biology start-ups with grant program

New project aims to develop entomological indicators to assess malaria control tools

Intense glucose therapy via IV insulin did not improve stroke outcomes, study finds

Researchers show efficacy of new therapy for amyotrophic lateral sclerosis in mice

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

A new treatment for Chlamydia via Canadian researchers

New breakthrough study can impact drug development and personalized medicine

Study shows no difference between relief offered by topical pain creams and placebos

Compounded pain relief creams not effective finds study

Research using fission yeast reveals anticancer mechanism

Are Electronic Cigarettes Facilitating Illicit Drug Use?

Self-care techniques should be first line of treatment for patients with facial pain, suggests study

Study: Promising new treatment for children with ADHD shows improvement in efficacy

Researchers unravel path of metallodrug in a breast cancer cell

Amprologix wins £1.2 million contract to tackle antimicrobial-resistant MRSA

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News